Telephone: 720-848-2292; FAX: 720-848-2246
Original Articles
Long-term management after liver transplantation: Primary care physician versus hepatologist†
Article first published online: 29 SEP 2009
DOI: 10.1002/lt.21786
Copyright © 2009 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Heller, J. C., Prochazka, A. V., Everson, G. T. and Forman, L. M. (2009), Long-term management after liver transplantation: Primary care physician versus hepatologist. Liver Transpl, 15: 1330–1335. doi: 10.1002/lt.21786
- †
See Editorial on Page 1162
- ‡
Telephone: 720-848-2292; FAX: 720-848-2246
Publication History
- Issue published online: 29 SEP 2009
- Article first published online: 29 SEP 2009
- Manuscript Accepted: 10 MAR 2009
- Manuscript Received: 13 NOV 2008
Funded by
- American Society of Transplantation/Schering Plough Women and Minority Career Development Faculty Grant
- Abstract
- Article
- References
- Cited By
Abstract
As long-term survival after liver transplantation increases, metabolic complications are becoming increasingly prevalent. Given concerns about which group of providers should be managing liver recipients and how well metabolic complications are managed, we administered a postal survey to 280 transplant hepatologists to determine attitudes, perceptions, and practice patterns in the management of metabolic complications after transplantation. The response rate was 68.2%. There was great variation in patterns of practice across the United States with respect to the number of posttransplant clinics, clinic format, and number of recipients cared for per week. Hepatologists, primary care physicians (PCPs), and surgeons were primarily responsible for the overall care of liver recipients 1 year or more after liver transplantation according to 66%, 24%, and 8% of respondents, respectively. Hepatologists felt that metabolic complications were common, but few strongly agreed that hypertension (33.3%), chronic renal insufficiency (3.8%), diabetes mellitus (8.8%), dyslipidemia (11.1%), and bone disease (12.8%) were well controlled. The majority of hepatologists indicated that ideally PCPs should be managing recipients' hypertension, diabetes mellitus, dyslipidemia, and bone disease (78.8%, 63.1%, 78.3%, and 72.5%), but they felt that in actuality, PCPs were managing these conditions less frequently (45.4%, 51.4%, 44.6%, and 38%). In conclusion, metabolic complications are perceived to be common but not well controlled post-transplant, and most hepatologists feel that PCPs should take a more active role in the management of these complications. Future studies are needed to identify barriers to care in the treatment of metabolic complications post-transplant with the goal of improving long-term morbidity and mortality. Liver Transpl 15:1330–1335, 2009. © 2009 AASLD.

1527-6473/asset/LT_left.gif?v=1&s=e1df7d33719b841a3479d2fd0a24baa5df4653e4)
1527-6473/asset/LT_right.gif?v=1&s=5deda9b4c4c603398e58a7274cf47e5b03ffc5fe)
1527-6473/asset/cover.gif?v=1&s=8c6a04b26832399220fbb731e05bd8cc9ff13ae2)